Magnetic Fluid Hyperthermia (MFH) uses heat generated by magnetic
nanoparticles exposed to alternating magnetic fields to cause a temperature
increase in tumors to the hyperthermia range (43–47 °C),
inducing apoptotic cancer cell death. As with all cancer nanomedicines, one of
the most significant challenges with MFH is achieving high nanoparticle
accumulation at the tumor site. This motivates development of synthesis
strategies that maximize the rate of energy dissipation of iron oxide magnetic
nanoparticles, preferable due to their intrinsic biocompatibility. This has led
to development of synthesis strategies that, although attractive from the point
of view of chemical elegance, may not be suitable for scale-up to quantities
necessary for clinical use. On the other hand, to date the aqueous
co-precipitation synthesis, which readily yields gram quantities of
nanoparticles, has only been reported to yield sufficiently high specific
absorption rates after laborious size selective fractionation. This work focuses
on improvements to the aqueous co-precipitation of iron oxide nanoparticles to
increase the specific absorption rate (SAR), by optimizing synthesis conditions
and the subsequent peptization step. Heating efficiencies up to 1,048
W/gFe (36.5 kA/m, 341 kHz; ILP = 2.3
nH·m2·kg−1) were obtained,
which represent one of the highest values reported for iron oxide particles
synthesized by co-precipitation without size-selective fractionation.
Furthermore, particles reached SAR values of up to 719 W/gFe (36.5
kA/m, 341 kHz; ILP = 1.6
nH·m2·kg−1) when in a solid
matrix, demonstrating they were capable of significant rates of energy
dissipation even when restricted from physical rotation. Reduction in energy
dissipation rate due to immobilization has been identified as an obstacle to
clinical translation of MFH. Hence, particles obtained with the conditions
reported here have great potential for application in nanoscale thermal cancer
therapy.